| abstract |
A compound of the formula (I): in which A = B = D represents NR10-C (O) -NR9, SC (O) -NR9, NR9-C (O) -S, NR9-C (O) O , CR10-C (O) -NR9, OC (O) -NR9, NR10-C (O) -CR, NR10-NR9-C (O), C (O) -NR9-NR10, NR10-N = CR9, N = N-CR9, NR10-CR9 = N, N = CR9-NR10, NR10-N = N, N = N-NR10, S-CR9 = N or N = CR9-S; X1 represents CR1; X2 and X3 each independently represents CR8; R1, R6, R8, R9 and R10 each independently represents hydrogen, halogen, hydroxyl, (C1-C6) alkyl, (C1-C8) alkoxy, (C1-C6) hydroxyalkoxy, (C1-C6) alkoxy-(C1 -C6), (C1-C6) alkoxy (C1-C6) alkoxy, (C1-C6) haloalkyl (C1-C6) alkylthio (C1-C6) alkylsulfinyl or (C1-C6) alkylsulfonyl; R2, R3, R4, and R5 each independently represent hydrogen, (C1-C6) alkyl, halogen, halo (C1-C6) alkyl or hydroxy (C1-C6) alkyl; and R7 represents halogen, (C1-C6) alkyl, halo (C1-C6) alkyl, (C1-C6) alkoxy, (C1-C6) hydroxyalkoxy, (C1-C6) alkoxy (C1-C8) alkyl, (C1 -C6) -C1-C6 alkoxy, [C1-C6 alkyl] NH- or [C1-C6 alkyl]] 2N-; or one of its pharmaceutically acceptable salts, with the proviso that: (i) when A = B = D represents NR10-N = N or N = N-NR10, then R2 represents (C1-C6) alkyl, halogen, haloalkyl ( C1-C6) or hydroxyalkyl (C1-C6); or (ii) when A = B = D represents NR10-N = N or N = N-NR10 and R2 represents (C1-C6) alkyl, then R7 represents halogen, (C1-C6) alkyl, (C1-C6) alkoxy , hydroxy (C1-C6) alkoxy, (C1-C6) alkoxy-(C1-C6) alkyl, (C1-C6) alkoxy (C1-C6) alkoxy, [(C1-C6) alkyl] NH- or [alkyl (C1-C6)] 2N-. |